Fosun Pharma (01652.HK): "Paramev Injection" has been approved for listing.

Tencent Finance APP News, Fosun Pharma (01652.HK) announced that its wholly-owned subsidiary Jiashen (Zhuhai Hengqin) Medical Technology Co., Ltd. has received approval from the China Food and Drug Administration for the listing application of the "Paramevir Injection" developed by the group, approved for the treatment of type A or B influenza.